Erin Wright

Q: What is Erin Wright's success rate?

Erin Wright currently has a success rate of 88.82033418116548.

Q: What is the average return of Erin Wright's calls?

Their stock ratings have generated an average return of 9.421875591292745.

Morgan Stanley | Healthcare

Erin Wright is an analyst from Morgan Stanley specializing in the Healthcare sector. Ranked #1829 out of 4752 analysts, they have issued 51 stock ratings with a success rate of 88.82% and an average return of 9.42%.

Erin Wright has a well-established track record, with 51 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 88.82% and an average return of 9.42%, underscoring their expertise and ability to identify winning opportunities for investors.

#1829

Out of 4752

Total Ratings

+88.82%

Success Rate

+9.42%

Average Return

Recent Ratings Analysis

HUM

Hold

Aug 05, 2026

Target

$370.00

Current

$363.82

Performance

0.00%

Erin Wright rated HUM as Equal-Weight on Aug 05, 2026, setting a price target of 370. The Hold stance appears justified, as shares hovered around 363.82 with a 0.00% move.

ZTS

Buy

Jul 22, 2026

Target

$99.00

Current

$74.40

Performance

0.28%

On Jul 22, 2026, ZTS was given a Overweight rating by Erin Wright, with a target price of 99. The stock traded sideways with a 0.28% move, keeping the bullish thesis unresolved.

ELAN

Hold

Jul 22, 2026

Target

$26.00

Current

$26.22

Performance

3.47%

ELAN received a Equal-Weight rating from Erin Wright on Jul 22, 2026, aiming for 26. Shares remained flat at 26.22, aligning with the neutral rating.

UNH

Buy

Jul 17, 2026

Target

$529.00

Current

$412.75

Performance

-3.13%

On Jul 17, 2026, Erin Wright published a Overweight outlook on UNH, with a target of 529. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 412.75.

BTSG

Buy

Jul 14, 2026

Target

$80.00

Current

$63.02

Performance

-9.54%

Erin Wright on Jul 14, 2026 assigned BTSG a Overweight rating, with a price target of 80. The call has struggled to gain traction, with shares losing 9.54%.

PSX

Buy

Jun 12, 2026

Target

$196.00

Current

$202.55

Performance

12.87%

On Jun 12, 2026, Erin Wright reaffirmed PSX with a Overweight rating, targeting 196. The recommendation was supported by strong follow-through as the stock rose from 202.55 to 202.55.

CVS

Buy

Jun 04, 2026

Target

$111.00

Current

$99.12

Performance

4.53%

CVS was rated Overweight by Erin Wright on Jun 04, 2026, with a price objective of 111. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

MOH

Hold

Jun 04, 2026

Target

$167.00

Current

$195.14

Performance

1.21%

On Jun 04, 2026, Erin Wright initiated coverage on MOH with a Equal-Weight rating and target of 167. The stock’s lack of movement around 195.14 aligned with a cautious approach.

ELV

Hold

Jun 04, 2026

Target

$404.00

Current

$391.24

Performance

-4.45%

Erin Wright issued a Equal-Weight recommendation for ELV on Jun 04, 2026, price target set at 404. The rating was appropriate for a consolidating market trading near 391.24.

CI

Buy

May 20, 2026

Target

$361.00

Current

$270.50

Performance

-4.45%

On May 20, 2026, CI was evaluated by Erin Wright, who gave a Overweight rating and target of 361. So far, the Buy call awaits clearer momentum, with shares flat at 270.5.

OPCH

Buy

May 06, 2026

Target

$485.00

Current

$23.70

Performance

15.89%

Erin Wright rated OPCH as Overweight on May 06, 2026, setting a price target of 485. The call has proven timely, with shares rising 15.89% toward the price target of 485.

NVST

Hold

Apr 24, 2026

Target

$21.00

Current

$28.66

Performance

—

On Apr 24, 2026, NVST was given a Equal-Weight rating by Erin Wright, with a target price of 21. Market indecision, reflected in sideways trading near 28.66, supported the cautious call.

HSIC

Sell

Apr 24, 2026

Target

$64.00

Current

$89.59

Performance

—

HSIC received a Underweight rating from Erin Wright on Apr 24, 2026, aiming for 64. Bearish momentum failed to push shares lower, as they hovered around 89.59.

ALGN

Hold

Apr 24, 2026

Target

$188.00

Current

$174.83

Performance

—

On Apr 24, 2026, Erin Wright published a Equal-Weight outlook on ALGN, with a target of 188. Sideways action left the Hold view intact, with no major move since 174.83.

COR

Buy

Jan 29, 2026

Target

$400.00

Current

$317.22

Performance

-9.91%

Erin Wright on Jan 29, 2026 assigned COR a Overweight rating, with a price target of 400. The call has struggled to gain traction, with shares losing 9.91%.

CAH

Buy

Jan 29, 2026

Target

$245.00

Current

$239.23

Performance

13.26%

On Jan 29, 2026, Erin Wright reaffirmed CAH with a Overweight rating, targeting 245. The recommendation was supported by strong follow-through as the stock rose from 239.23 to 239.23.

MCK

Buy

Nov 06, 2025

Target

$916.00

Current

$879.48

Performance

2.43%

MCK was rated Overweight by Erin Wright on Nov 06, 2025, with a price objective of 916. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

IDXX

Buy

Nov 04, 2025

Target

$805.00

Current

$584.78

Performance

-19.02%

On Nov 04, 2025, Erin Wright initiated coverage on IDXX with a Overweight rating and target of 805. The Buy call has yet to be validated as shares remain 220.22 away from the target.

PAHC

Hold

Jun 25, 2025

Target

$26.00

Current

$36.01

Performance

45.49%

Erin Wright issued a Equal-Weight recommendation for PAHC on Jun 25, 2025, price target set at 26. A neutral call gave way to stronger-than-expected performance, closing in on 26.

XRAY

Buy

Dec 17, 2024

Target

$23.00

Current

$13.78

Performance

-28.19%

On Dec 17, 2024, XRAY was evaluated by Erin Wright, who gave a Overweight rating and target of 23. Investors saw limited payoff as shares fell short of the 23 target.

PDCO

Hold

Dec 17, 2024

Target

$31.35

Current

$31.33

Performance

1.39%

Erin Wright rated PDCO as Equal-Weight on Dec 17, 2024, setting a price target of 31.35. The Hold stance appears justified, as shares hovered around 31.33 with a 1.39% move.

WBA

Sell

Oct 11, 2024

Target

$7.00

Current

$11.98

Performance

30.08%

On Oct 11, 2024, WBA was given a Underweight rating by Erin Wright, with a target price of 7. The Sell stance aligned with downward action, with the stock sliding from 11.98 to 11.98.

Frequency Asked Questions

Who is Erin Wright?

Erin Wright is an analyst from Morgan Stanley specializing in the Healthcare sector.

What is Erin Wright's success rate?

Erin Wright currently has a success rate of +88.82%.

How many ratings has Erin Wright issued?

Erin Wright has issued 51 stock ratings so far.

What is the average return of Erin Wright's calls?

Their stock ratings have generated an average return of +9.42%.

What is Erin Wright's ranking?

Erin Wright is ranked #1829 out of 4752 analysts.

What types of ratings does Erin Wright give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Erin Wright?

You can follow Erin Wright by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Erin Wright?

Their latest rating was a Hold on HUM issued on 2026-08-05.